5'-Guanidinonaltrindole, a highly selective and potent κ-opioid receptor antagonist

European Journal of Pharmacology

Volumn 396, Issue 1, 2000, Pages 49-52

  Jones, Robert M ^a   Portoghese, Philip S ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Opioid receptor; Binding; Norbinaltorphimine

Indexed keywords

3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE METHANESULFONATE; 5' GUANIDINONALTRINDOLE; DYNORPHIN A [1-11]; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; ENKEPHALIN[2 DEXTRO ALANINE 5 DEXTRO LEUCINE]; ENKEPHALIN[2,5 DEXTRO PENICILLAMINE]; ETHYLKETAZOCINE; KAPPA OPIATE RECEPTOR; KAPPA OPIATE RECEPTOR ANTAGONIST; MORPHINE; NOCICEPTIN; NORBINALTORPHIMINE; OPIATE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CHO CELL; CONTROLLED STUDY; GENE EXPRESSION; GUINEA PIG; HUMAN; ILEUM; IN VITRO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BINDING; SMOOTH MUSCLE CONTRACTION; VAS DEFERENS;

ANIMALS; CHO CELLS; CRICETINAE; ENKEPHALIN, ALA(2)-MEPHE(4)-GLY(5)-; ENKEPHALIN, D-PENICILLAMINE (2,5)-; GUINEA PIGS; HUMANS; LIGANDS; MALE; MEMBRANES; MICE; MICE, INBRED ICR; MUSCLE, SMOOTH; NALTREXONE; RECEPTORS, OPIOID, KAPPA;

EID: 0034640189     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(00)00208-9     Document Type: Article

References (12)

1. 35S]GTPγS binding: a tool to evaluate functional activity of a cloned receptor transiently expressed in COS cells. Neurochem. Res. 21:1996;1301-1307.
2. 50) of an enzymatic reaction. Biochem. Pharmacol. 22:1973;3099-3108.
3. Dhawan B.N., Cesselin F., Raghubir R., Reisine T., Bradley P.B., Portoghese P.S., Hamon M. International Union of Pharmacology:XII. Classification of opioid receptors. Pharmacol. Rev. 48:1996;567-592.
4. Henderson G., Hughes J., Kosterlitz H.W. A new example of a morphine-sensitive neuro-effector junction: adrenergic transmission in the mouse vas deferens. Br. J. Pharmacol. 46:1972;764-766.
5. Hjorth S.A., Thirstrup K., Grandy D.K., Schwartz T.W. Analysis of selective binding epitopes for the κ-opioid receptor antagonist nor-binaltorphimine. Mol. Pharmacol. 47:1995;1089-1094.
6. Jones R.M., Hjorth S.A., Schwartz T.W., Portoghese P.S. Mutational evidence for a common κ antagonist binding pocket in the wild-type κ and mutant μ[K303E] opioid receptors. J. Med. Chem. 41:1998;4911-4914.
7. 2-alkylamidino)methyl]naltrindole derivatives as a novel class of kappa opioid receptor antagonists. J. Med. Chem. 36:1993;179-180.
8. Paterlini M.G., Portoghese P.S., Ferguson D.M. Simulation of dynorphin A(1-10) binding to extracellular loop 2 of the κ opioid receptor. A model for receptor activation. J. Med. Chem. 40:1997;3254-3262.
9. Portoghese P.S., Sultana M., Takemori A.E. Design of peptidomemetic δ opioid receptor antagonists using the message-address concept. J. Med. Chem. 33:1990;1714-1720.
10. Rang H.P. Stimulant actions of volatile anesthetics on smooth muscle. Br. J. Pharmacol. 22:1964;356-365.
11. Subramanian G., Paterlini M.G., Larson D.L., Portoghese P.S., Ferguson D.M. Confromational analysis and automated receptor docking of selective arylacetamide-based κ-agonists. J. Med. Chem. 41:1998;4177-4180.
12. Takemori A.E., Portoghese P.S. Selective naltrexone-derived opioid receptor antagonists. Annu. Rev. Pharmacol. Toxicol. 32:1992;239-269.